Category: Diagnostics

AcouSort AB has recently made waves in the biopharmaceutical industry by securing a technology evaluation agreement with Danish diagnostics company SeeQ Diagnostics. This strategic collaboration aims to evaluate AcouSort’s cutting-edge blood/plasma separation technology for the seamless preparation of blood samples on SeeQ’s diagnostic platform, SepSeeQ. The partnership is poised to revolutionize the diagnostic landscape, as […]

In the intricate world of hemostasis diagnostics, where precision is paramount and variability can spell disaster, the concept of assay reproducibility emerges as a critical element in ensuring the reliability of trial outcomes. Like a skilled conductor orchestrating a symphony, the ability to reduce variability and strengthen the consistency of assay results is essential for […]

Artificial intelligence (AI) has made significant strides in healthcare, with applications ranging from diagnostics to treatment planning. A recent study delved into the realm of AI-based electrocardiogram interpretation (AI-ECG) in detecting left ventricular systolic dysfunction (LVSD) in patients with muscular dystrophy. This study sheds light on the potential of AI to revolutionize cardiac risk assessment […]

Hey there, health enthusiasts and curious minds! Today, we’re diving into the exciting realm of pediatric gastroenterology to explore how fecal calprotectin levels can revolutionize the detection of treatable enteric pathogens in children battling severe acute diarrheal disease, particularly in the vibrant land of Botswana. So, buckle up and let’s embark on this exhilarating scientific […]

Natera, a trailblazer in the biotech industry, has garnered attention as its stock price skyrockets and revenues soar exponentially. Celebrating its 10th year as a public company, Natera has seen its stock value surge from $18 to approximately $170, delivering remarkable returns to its investors. The company’s revenue growth, expanding tenfold from $190 million to […]

In the fast-paced world of healthcare, precision medicine is on the rise, prompting health systems to embrace digital innovations for better patient outcomes. Mayo Clinic Laboratories, at the forefront of this revolution, is leveraging the potential of AI and big data to democratize diagnostics, making healthcare more accessible and effective than ever before. The Evolution […]

In a recent development in the Philippines, Concentrix, a leading Fortune 500® technology and services organization and the country’s largest private employer with a workforce exceeding 100,000, has introduced a groundbreaking initiative named KALIX. This innovative concept represents an industry-first integrated health hub designed to cater to its employees and eligible dependents, setting a new […]

Access to cutting-edge diagnostic technologies like blood-based biomarkers for early Alzheimer’s detection and treatment remains a significant challenge in the United States. Fujirebio Diagnostics’ Lumipulse test, measuring the pTau-217 to beta amyloid 42 ratio, offers crucial insights into amyloid pathology with a remarkable 92% positive predictive value and 97% negative predictive value. Labcorp’s Chief Medical […]

Altesa BioSciences and bioMérieux have joined forces in a groundbreaking collaboration set to revolutionize the treatment landscape for Chronic Obstructive Pulmonary Disease (COPD). This strategic partnership is poised to introduce a pivotal Phase 2B clinical trial that promises to enhance patient outcomes and significantly impact respiratory healthcare. A Fresh Approach to COPD Treatment Altesa BioSciences, […]

In the realm of cancer diagnostics, Johns Hopkins investigators have once again made a groundbreaking stride with the development of a novel urine-based test for the identification of prostate cancers. This innovative approach holds the promise of transforming the landscape of prostate cancer screening, offering a non-invasive and reliable method for early detection. Let’s delve […]

Concentrix, a leading global technology and services provider and the largest private employer in the Philippines with a workforce exceeding 100,000 employees, has introduced a groundbreaking initiative known as KALIX. This innovative integrated health hub, uniquely designed by Concentrix, aims to cater to its employees, referred to as game-changers, and their eligible dependents. Inspired by […]

The Molecular Diagnostics Market is on a trajectory towards substantial growth, with a projected valuation of US$30.74 billion by 2030 and a robust CAGR of 9.6% from 2025 to 2030. This upward trend is fueled by increased government funding in precision medicine and genomics, driving the adoption of molecular diagnostic kits and instruments. The escalating […]

The emergence of brain-computer interfaces (BCIs) like Neuralink, Synchron, and Blackrock Neurotech represents a significant leap in merging technology with the human brain, offering hope for treating conditions such as paralysis, epilepsy, and Alzheimer’s, while also potentially enhancing memory and cognition. While these advancements hold great promise, they come with a host of ethical dilemmas […]

A groundbreaking new breath sensor has been developed to detect diabetes in a matter of minutes, utilizing the presence of acetone in exhaled breath as a key indicator of the disease. Acetone, a volatile organic compound found in breath, is typically present in small amounts but can significantly increase in individuals with diabetes. This innovative […]

MDxHealth SA, a precision diagnostics company, celebrated a significant milestone in the second quarter by achieving its first quarter of operating profitability. The company reported positive adjusted EBITDA of $1.4 million, a notable turnaround from a loss of $4.9 million a year earlier. This achievement was accompanied by a 20% increase in revenue to $26.6 […]

In a groundbreaking partnership, Corewell Health, a healthcare leader, and Quest Diagnostics, a renowned provider of diagnostic services, have announced their collaboration to establish a cutting-edge diagnostic laboratory. This joint venture, named Diagnostic Lab of Michigan, LLC, will be housed within a state-of-the-art facility at Corewell Health’s Southfield Center. Scheduled to commence operations in the […]

EKF Diagnostics recently secured three new contracts totaling €4.65m in the Hematology point-of-care testing segment, a key area for the company’s organic growth. These contracts, to be fulfilled over the next 12 to 24 months, involve supplying haemoglobin analyzers and related consumables through distribution partners in Latin America and Africa. One of the contracts signifies […]

Technology has made remarkable strides in various fields, revolutionizing how we live and work. Despite these advancements, there are still critical real-world problems that technology has yet to effectively address. From labor shortages to healthcare disparities, misinformation spread to data security risks, there are numerous areas where better and faster technological applications could catalyze meaningful […]

The global In Vitro Diagnostic (IVD) Antibodies Market is expected to witness substantial growth, with projections indicating a rise from USD 1.4 billion in 2025 to USD 2.0 billion by 2035, showcasing a Compound Annual Growth Rate (CAGR) of 3.8% over the forecast period. This growth is primarily attributed to the increasing prevalence of chronic […]

Thermo Fisher Scientific has received FDA approval for its Oncomine Dx Target Test as a companion diagnostic for identifying patients suitable for HERNEXEOS treatment, a tyrosine kinase inhibitor developed by Boehringer Ingelheim. Through this test, clinicians can determine if non-small cell lung cancer (NSCLC) tumors carry human epidermal growth factor receptor 2 (HER2/ERBB2) tyrosine kinase […]

The Laboratory Developed Tests (LDTs) market is set to exceed USD 23.03 billion by 2032, driven by the increasing demand for personalized diagnostics and the detection of chronic diseases. These tests, crucial for specialized diagnostics such as genetic screening, oncology, rare diseases, and infectious diseases, are experiencing rapid expansion globally. Factors contributing to this growth […]

Fujirebio Diagnostics employees in Malvern played a crucial role in developing a new Alzheimer’s blood test. They assessed the performance of the test’s components, determined the optimal ratio for the components, and defined the values for a positive test result. Additionally, the team in Malvern prepared the FDA application for the test, showcasing their expertise […]